|

CD79b-19 CAR T cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Marcela V. Maus, M.D.,Ph.D.1

Indications

  • Grade 3b Follicular Lymphoma1
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)1
  • High-grade B-cell Lymphoma1
  • Refractory Non-Hodgkin Lymphoma1
  • Relapsed Non-Hodgkin Lymphoma1

Boston, Massachusetts1 trial

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Massachusetts General Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.